Helius Medical Technologies (HSDT) News Today

Helius Medical Technologies, Inc. (NASDAQ:HSDT) shares moved higher after the company unveiled a sizable Solana (SOL) token acquisition as part of its new digital asset treasury strategy. Investors reacted to both the announcement details and subsequent trading halts/resumptions.

Key developments driving HSDT’s price action:

• Positive Sentiment: Shares rallied ~8.5% in after-hours trading following HSDT’s announcement of a Solana purchase valued at approximately $175 million. Helius Medical Stock Pops 8.5% After Hours On Solana Treasury Purchases
• Positive Sentiment: Helius disclosed the acquisition of 760,190 SOL tokens at an average cost basis of $231 and confirmed it holds over $335 million in cash to further its digital asset treasury strategy. Quiver Quantitative: Acquisition of Solana Tokens
• Neutral Sentiment: Trading in HSDT shares was halted and later resumed due to a volatility (LULD) pause around the time of the SOL purchase announcement. MSN: Trading Halted, Volatility Trading Pause
• Neutral Sentiment: HSDT trading was briefly paused under the exchange’s LULD mechanism at 3:09 PM on Sept. 22 before resuming normal activity.
• Neutral Sentiment: Helius outlined a broader $500 million Solana-focused treasury program, launching with the initial 760,190 SOL acquisition. FinanceFeeds: $500M Solana Treasury Kickoff
• Negative Sentiment: Solana’s price fell over 6% despite Helius’ large SOL purchase, which may weigh on the value of its newly acquired tokens. FXStreet: Solana Drops Over 6%